CDKN2A and amyotrophic lateral sclerosis: Primary microglia obtained from an amyotrophic lateral sclerosis (ALS) rat model expressing SOD1G93A developed flat morphology, SA β-gal, and increased expressions of p16, p53, and MMP-1 at 12 days in vitro compared to 2 days in vitro.